Signup Crypto ETF Stocks News

AppLovin Corporation ( APP ) Market Value Craters $20 Billion On March 27 After Muddy Waters Takes Aim, Class Action Pending - Hagens Berman - AppLovin ( NASDAQ:APP )

SAN FRANCISCO, March 28, 2025 ( GLOBE NEWSWIRE ) -- On March 27, 2025, investors in AppLovin ( NASDAQ:APP ) saw the price of their shares drop $65.92, wiping out about $20 billion of the company's market value, after prominent short seller Muddy Waters Research revealed its short position in the ...

Source: www.benzinga.com
March 28, 2025 | 22:07:35
Category: News

Crave Original Series EMPATHIE honoured at Series Mania Festival

Written by Florence Longpré and directed by Guillaume Lonergan, EMPATHIE earns the Audience Award The Crave Original series from Québec premieres on April 10, in English and French

Source: www.benzinga.com
March 28, 2025 | 22:08:00
Category: News

Senators press regulators on Trump's WLFI stablecoin

Five Democratic lawmakers in the US Senate have called on leadership at regulatory agencies to consider the potential conflicts of interest from a stablecoin launched by World Liberty Financial ( WLFI ) , the crypto firm backed by US President Donald Trump's family.In a March 28 letter from the ...

Source: cointelegraph.com
March 28, 2025 | 22:10:00
Category: News

Here's How Much You Would Have Made Owning Glaukos Stock In The Last 5 Years - Glaukos ( NYSE:GKOS )

Glaukos GKOS has outperformed the market over the past 5 years by 10.4% on an annualized basis producing an average annual return of 27.01%. Currently, Glaukos has a market capitalization of $5.83 billion.

Source: www.benzinga.com
March 28, 2025 | 22:15:12
Category: News

Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors ...

Source: www.globenewswire.com
March 28, 2025 | 20:07:00
Category: News

Press Release: Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors Qfitlia ( fitusiran ) , the first antithrombin-lowering therapy in hemophilia, offers consistent protection with as few as six injections a year via a prefilled pen or vial and syringe

Source: www.benzinga.com
March 28, 2025 | 20:07:23
Category: News

US regulators FDIC and CFTC ease crypto restrictions for banks, derivatives

The Federal Deposit Insurance Corporation ( FDIC ) said in a March 28 letter that institutions under its oversight, including banks, can now engage in crypto-related activities without prior approval. The announcement comes as the Commodity Futures Trading Commission ( CFTC ) announced that ...

Source: cointelegraph.com
March 28, 2025 | 20:08:11
Category: News

FutureFuel Releases 2024 Results

Reports Net Income of $15.5 Million or $0.35 per Diluted Share, and Adjusted EBITDA of $17.6 Million Reports Net Income of $15.5 Million or $0.35 per Diluted Share, and Adjusted EBITDA of $17.6 Million ...

Source: www.globenewswire.com
March 28, 2025 | 20:10:00
Category: News

Genelux Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

- Alignment reached with U.S. Food and Drug Administration on key elements of the approval pathway for Olvi-Vec in Platinum Resistant/Refractory Ovarian Cancer ...

Source: www.globenewswire.com
March 28, 2025 | 20:10:00
Category: News

Public Keys: GameStop Wants Bitcoin, Miners Face Shrinkage, Robinhood Gets a Time Out

Traders are cashing in on GameStop's fumbled Bitcoin announcement and BTC miners are in for a world of hurt as fees shrink.

Source: decrypt.co
March 28, 2025 | 20:11:17
Category: News

© Natavest 2025 - 2026